omniture
logo
Search
I-MAB Biopharma Co., Ltd.
Media Room

Photo News

rss
I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC

I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC

2023-07-05 20:00 1874
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022

I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022

2022-08-30 18:00 2368
I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board

I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board

2020-12-01 21:00 3227
I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome

I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome

2020-05-28 04:05 1883